Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer’s Disease Pathology

Abstract

Background: Amyloid-β (Aβ) oligomers induce the overproduction of phosphorylated tau and neurodegeneration. These cascades gradually cause cognitive impairment in Alzheimer’s disease (AD). While each pathological event in AD has been studied in detail separately, the spatial and temporal relationships between pathological events in AD remain unclear. Objective: We demonstrated that lipid rafts function as a common platform for the pathological cascades of AD. Methods: Cellular and synaptosomal lipid rafts were prepared from the brains of Aβ amyloid model mice (Tg2576 mice) and double transgenic mice (Tg2576 x TgTauP301L mice) and longitudinally analyzed. Results: Aβ dimers, the cellular prion protein (PrPc), and Aβ dimer/PrPc complexes were detected in the lipid rafts. The levels of Fyn, the phosphorylated NR2B subunit of the N-methyl-D-aspartate receptor, glycogen synthase kinase 3β, total tau, phosphorylated tau, and tau oligomers increased with Aβ dimer accumulation in both the cellular and synaptosomal lipid rafts. Increases in the levels of these molecules were first seen at 6 months of age and corresponded with the early stages of Aβ accumulation in the amyloid model mice. Conclusion: Lipid rafts act as a common platform for the progression of AD pathology. The findings of this study suggest a novel therapeutic approach to AD, involving the modification of lipid raft components and the inhibition of their roles in the sequential pathological events of AD.

The Intersection of cerebral cholesterol metabolism and Alzheimer's disease: Mechanisms and therapeutic prospects

“…Cholesterol molecules are not uniformly distributed on the cell membrane but are enriched in specific membrane regions along with sphingolipids and glycosphingolipids, forming what is known as lipid rafts ( Table 2 ) [ 72 ]. Rafts, as cholesterol-rich membrane domains, contain proteins involved in enzymatic cleavage, constituting heterogeneous and highly dynamic components of the cell membrane.…”

Research progress of ferroptosis in Alzheimer disease: A review

“…The findings of this longitudinal investigation revealed that lipid rafts serve as a shared platform for the pathological progression of AD. [37] Furthermore, the up-regulation of AMPK, a crucial regulator of ferroptosis lipid peroxidation, not only inhibits phospholipid synthesis but also exerts an inhibitory effect on the phosphorylation of tau protein. [38] Therefore, in addition to being an important marker of ferroptosis, lipid peroxidation also plays a role in AD.…”

Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer’s Disease?

“…The whole of these data suggest that raft lipid domain could play a role of "mediator". Indeed, accumulating evidence suggests the possibility of a local and transient co-presence of Aβ and tau, at high local concentration, in the microdomain raft region of plasma membrane, enhanced by pathological condition [74,79]. Thus, lipid membrane could be the interface where Aβ and tau proteins mutually cross interact.…”